Showing results (51-60 of 127) with videos related to

Sort By:
Pageof 13
Acta Oncologica (Stockholm, Sweden)|January 23, 2016
Impact of hydrogel spacer injections on interfraction prostate motion during prostate cancer radiotherapyCristina Picardi, Michel Rouzaud, Melpomeni Kountouri, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 27, 2006
Guidelines for primary radiotherapy of patients with prostate cancerDirk Boehmer, Philippe Maingon, Philip Poortmans, et al.
Acta Oncologica (Stockholm, Sweden)|April 3, 2013
Androgen deprivation and high-dose radiotherapy for oligometastatic prostate cancer patients with less than five regional and/or distant metastasesUlrike Schick, Sandra Jorcano, Philippe Nouet, et al.
Physics and Imaging in Radiation Oncology|January 18, 2021
Clinical experience with lung-specific electromagnetic transponders for real-time tumor tracking in lung stereotactic body radiotherapyMaud Jaccard, Ambroise Champion, Angèle Dubouloz, et al.
Radiation Oncology (London, England)|October 24, 2012
Impact of 18F-FDG PET/CT on target volume delineation in recurrent or residual gynaecologic carcinomaHansjörg Vees, Nathalie Casanova, Thomas Zilli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 11, 2007
Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancerDaniela B Husarik, Raymond Miralbell, Markus Dubs, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 12, 2010
Boosting the tumor bed from deep-seated tumors in early-stage breast cancer: a planning study between electron, photon, and proton beamsJosé I Toscas, Dolors Linero, Isabel Rubio, et al.
Radiation Oncology (London, England)|June 28, 2011
Breathing adapted radiotherapy: a 4D gating software for lung cancerNicolas Peguret, Jacqueline Vock, Vincent Vinh-Hung, et al.
BJU International|April 13, 2007
18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomyHansjörg Vees, Franz Buchegger, Susanne Albrecht, et al.
International Journal of Radiation Oncology, Biology, Physics|March 3, 2009
Hypofractionated boost with high-dose-rate brachytherapy and open magnetic resonance imaging-guided implants for locally aggressive prostate cancer: a sequential dose-escalation pilot studyCarmen Ares, Youri Popowski, Sandro Pampallona, et al.
Pageof 13